CPIX Cumberland Pharmaceuticals Inc Net Sales Margin

Brandmark of Cumberland Pharmaceuticals Inc (CPIX)

Logistics disruptions caused by trade conflicts are hindering raw material supplies for Cumberland Pharmaceuticals (CPIX). The final sales margin confirms this pressure, where the value -47.00 records the metric level. Stability is maintained through the modernization of production facilities and the acquisition of niche hospital brands, which are shielded from price wars due to direct contracts with medical centers.

Cumberland Pharmaceuticals (CPIX) - Net Margin from 07/04/2022 to 11/19/2026

Financial and market metric breakdowns for Cumberland Pharma (CPIX)

- market value and analyst target forecast:
Initial company analysis:Cumberland Pharmaceuticals
Manufactured product of Cumberland Pharmaceuticals Inc

The analyst assesses business resilience to costs through the ability to generate free cash flow. Cumberland Pharmaceuticals (CPIX) monetizes hospital drugs for the therapy of pain and infections. The net margin of trading and production activities reflects the share of profit after deducting all operating and financial obligations. This indicator measures the final efficiency of each unit of revenue. A stable level confirms the reliability of the model, while sharp spikes signal one-time expenses.

Key competitors

HLN: Net Sales Margin|Net Return on Sales KVUE|Net Margin veronapharma.com|Net Return on Sales MENS (Jyong Biotech Corp)|Net Margin Ligand (LGND)|Net Sales Margin amneal.com (AMRX)|Net Sales Margin PRGO (perrigo.com)|Alvotech SA (ALVO) - Net Margin|Liquidia Inc. - Net Sales Margin|Net Profitability Margin Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Net Margin|Net Return on Sales MNKD|Net Margin Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Company Sales Margin|Net Sales Margin SPRY|TBPH - Net Margin|Aquestive Pharma - Return on Sales by Net Profit|Net Sales Margin scpharmaceuticals.com SCPH|Tectonic - Net Sales Margin|TNXP - Net Sales Margin|SXTC: Net Sales Margin|Eupraxia Pharma - Net Profit Rate|BHST (bioharvest.com) - Net Sales Margin|Net Return on Sales EXOZ (invizyne.com)|Net Sales Margin ORMP|Company Sales Margin Entera Bio|Net Sales Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Net Margin|Quantum BioPharma Corp - Net Sales Margin|FGEN (fibrogen.com) - Net Return on Sales|TELO (Telomir Pharmaceuticals) - Return on Sales by Net Profit|Rani Therapeutics Holdings - Net Profit Rate|Return on Sales by Net Profit SNYR|Net Margin rallybio.com RLYB|Net Sales Margin LEXX|PULM (Pulmatrix, Inc.) - Net Profit Rate|Pheton Holdings - Return on Sales by Net Profit|Net Sales Margin Aptorum Group Limited APM|LYRA: Return on Sales by Net Profit|IBO: Net Margin|TNFA: Net Sales Margin|YCBD: Company Net Profitability|Net Margin PainReform Ltd|CYTO (altamiratherapeutics.com) - Company Net Profitability|Net Sales Margin LIPO|OPTN - Net Margin|Net Margin pieris.com PIRS|Net Profit Rate PROC|PTPI - Net Margin|Qilian International Holding (QLI) - Return on Sales by Net Profit|SLRN: Net Sales Margin|Return on Sales by Net Profit TFF Pharma